These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7691443)

  • 1. Modified assay of prostate-specific antigen with a detection limit < 0.01 microgram/L.
    Liedtke RJ; Kroon G; Batjer JD
    Clin Chem; 1993 Oct; 39(10):2150-4. PubMed ID: 7691443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
    Vessella RL; Noteboom J; Lange PH
    Clin Chem; 1992 Oct; 38(10):2044-54. PubMed ID: 1382897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ultrasensitive immunoassay for prostate-specific antigen based on conventional colorimetric detection.
    Khosravi MJ; Papanastasiou-Diamandi A; Mistry J
    Clin Biochem; 1995 Aug; 28(4):407-14. PubMed ID: 8521595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
    Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
    Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen.
    Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB
    Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
    Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A
    Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.
    Stamey TA; Graves HC; Wehner N; Ferrari M; Freiha FS
    J Urol; 1993 Apr; 149(4):787-92. PubMed ID: 7681119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique.
    Yu H; Diamandis EP
    J Urol; 1995 Mar; 153(3 Pt 2):1004-8. PubMed ID: 7531781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L.
    Yu H; Diamandis EP; Wong PY; Nam R; Trachtenberg J
    J Urol; 1997 Mar; 157(3):913-8. PubMed ID: 9072598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical performance and clinical validity of two free prostate-specific antigen assays compared.
    Jung K; Stephan C; Lein M; Henke W; Schnorr D; Brux B; Schürenkämper P; Loening SA
    Clin Chem; 1996 Jul; 42(7):1026-33. PubMed ID: 8674185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasensitive radioimmunoassay of prostate-specific antigen.
    Graves HC; Wehner N; Stamey TA
    Clin Chem; 1992 May; 38(5):735-42. PubMed ID: 1374691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
    van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
    Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies.
    Yu H; Diamandis EP
    Clin Chem; 1993 Oct; 39(10):2108-14. PubMed ID: 7691442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)--multi-centre study results. The PSA Study Group.
    Schambeck CM
    Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):541-7. PubMed ID: 8547440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen.
    Blijenberg BG; Eman I; Boevé ER; Mössner E; Uhl W
    Eur J Clin Chem Clin Biochem; 1995 Jun; 33(6):383-92. PubMed ID: 7578619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology.
    McDermed JE; Sanders R; Fait S; Klem RE; Sarno MJ; Adams TH; Diamandis EP
    Clin Chem; 2012 Apr; 58(4):732-40. PubMed ID: 22361936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy.
    Yu H; Diamandis EP; Prestigiacomo AF; Stamey TA
    Clin Chem; 1995 Mar; 41(3):430-4. PubMed ID: 7533672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.
    Oberpenning F; Weining C; Brandt B; De Angelis G; Heinecke A; Hamm M; Stieber P; Hertle L; Schmid HP; Semjonow A
    Clin Chem Lab Med; 2003 Jan; 41(1):90-4. PubMed ID: 12636056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared.
    Chan DW; Bruzek DJ; Oesterling JE; Rock RC; Walsh PC
    Clin Chem; 1987 Oct; 33(10):1916-20. PubMed ID: 2444361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a highly sensitive immunochemiluminometric assay for prostate-specific antigen.
    Klee GG; Preissner CM; Oesterling JE
    Urology; 1994 Jul; 44(1):76-82. PubMed ID: 7518985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.